These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23657454

  • 1. Detection of EPO injections using a rapid lateral flow isoform test.
    Lönnberg M, Lundby C.
    Anal Bioanal Chem; 2013 Dec; 405(30):9685-91. PubMed ID: 23657454
    [Abstract] [Full Text] [Related]

  • 2. Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.
    Dehnes Y, Shalina A, Myrvold L.
    Drug Test Anal; 2013 Dec; 5(11-12):861-9. PubMed ID: 24190107
    [Abstract] [Full Text] [Related]

  • 3. MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples.
    Dehnes Y, Myrvold L, Ström H, Ericsson M, Hemmersbach P.
    Drug Test Anal; 2014 Dec; 6(11-12):1144-50. PubMed ID: 25421537
    [Abstract] [Full Text] [Related]

  • 4. Detection of microdoses of rhEPO with the MAIIA test.
    Mørkeberg J, Sharpe K, Karstoft K, Ashenden MJ.
    Scand J Med Sci Sports; 2014 Aug; 24(4):634-41. PubMed ID: 23347069
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the MAIIA dipstick test to detect recombinant human erythropoietin in plasma.
    Ashenden M, Sharpe K, Garnham A, Gore CJ.
    J Pharm Biomed Anal; 2012 Aug; 67-68():123-8. PubMed ID: 22578970
    [Abstract] [Full Text] [Related]

  • 6. New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.
    Martin L, Ashenden M, Bejder J, Hoffmann M, Nordsborg N, Karstoft K, Morkeberg J, Sharpe K, Lasne F, Marchand A.
    Drug Test Anal; 2016 Nov; 8(11-12):1119-1130. PubMed ID: 27390252
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
    Ashenden M, Gough CE, Garnham A, Gore CJ, Sharpe K.
    Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport.
    Abellan R, Ventura R, Pichini S, Remacha AF, Pascual JA, Pacifici R, Di Giovannandrea R, Zuccaro P, Segura J.
    J Pharm Biomed Anal; 2004 Sep 03; 35(5):1169-77. PubMed ID: 15336362
    [Abstract] [Full Text] [Related]

  • 11. Strategies for rhEPO detection in sport.
    Kazlauskas R, Howe C, Trout G.
    Clin J Sport Med; 2002 Jul 03; 12(4):229-35. PubMed ID: 12131056
    [Abstract] [Full Text] [Related]

  • 12. Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation.
    Morkeberg J, Lundby C, Nissen-Lie G, Nielsen TK, Hemmersbach P, Damsgaard R.
    Med Sci Sports Exerc; 2007 Oct 03; 39(10):1742-7. PubMed ID: 17909401
    [Abstract] [Full Text] [Related]

  • 13. Rapid detection of erythropoiesis-stimulating agents in urine and serum.
    Lönnberg M, Andrén M, Birgegård G, Drevin M, Garle M, Carlsson J.
    Anal Biochem; 2012 Jan 15; 420(2):101-14. PubMed ID: 22005323
    [Abstract] [Full Text] [Related]

  • 14. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes.
    Parisotto R, Gore CJ, Emslie KR, Ashenden MJ, Brugnara C, Howe C, Martin DT, Trout GJ, Hahn AG.
    Haematologica; 2000 Jun 15; 85(6):564-72. PubMed ID: 10870111
    [Abstract] [Full Text] [Related]

  • 15. Monitoring recombinant human erythropoietin abuse among athletes.
    Citartan M, Gopinath SCB, Chen Y, Lakshmipriya T, Tang TH.
    Biosens Bioelectron; 2015 Jan 15; 63():86-98. PubMed ID: 25058943
    [Abstract] [Full Text] [Related]

  • 16. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R, Ventura R, Pichini S, Palmi I, Bellver M, Olive R, Pacifici R, Pascual JA, Zuccaro P, Segura J.
    Int J Sports Med; 2007 Jan 15; 28(1):9-15. PubMed ID: 16804802
    [Abstract] [Full Text] [Related]

  • 17. GASepo-a software solution for quantitative analysis of digital images in Epo doping control.
    Bajla I, Holländer I, Minichmayr M, Gmeiner G, Reichel Ch.
    Comput Methods Programs Biomed; 2005 Dec 15; 80(3):246-70. PubMed ID: 16260062
    [Abstract] [Full Text] [Related]

  • 18. Detection in blood and urine of recombinant erythropoietin administered to healthy men.
    Wide L, Bengtsson C, Berglund B, Ekblom B.
    Med Sci Sports Exerc; 1995 Nov 15; 27(11):1569-76. PubMed ID: 8587495
    [Abstract] [Full Text] [Related]

  • 19. Dried blood spots for erythropoietin analysis: Detection of micro-doses, EPO c.577del variant and comparison with in-competition matching urine samples.
    Heiland CE, Martin L, Zhou X, Zhang L, Ericsson M, Marchand A.
    Drug Test Anal; 2024 Jun 15; 16(6):650-654. PubMed ID: 37942506
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.